SMS Pharmaceuticals eyeing to demerge Non-FDA Manufacturing Units

09 Feb 2015 Evaluate

SMS Pharmaceuticals has received an approval for appointment of an Independent Committee to explore the possibilities of demerger of Non-FDA Manufacturing Units of the company. The board of directors at their meeting held on February 06, 2015 have approved for the same.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. The company is diversifying into CRAMS by creating research and manufacturing facilities bettering the requirements of the regulatory markets to appeal to international clientele.

SMS Pharmaceuticals Share Price

207.80 -1.10 (-0.53%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.